Light emitting diode (LED) device manufacturer Celluma has now launched in the UK after being available in the US since 2013.
The company has a portfolio of five LED devices that use proprietary phototherapeutic technologies to treat skin,muscle and joint conditions including acne and facial wrinkles.
The flagship device, Celluma PRO has been cleared by the Food and Drug Administration (FDA) to treat acne, wrinkles and a variety of musculoskeletal and pain conditions. It is also CE marked as a Class IIa medical device for dermal wound healing.
According to the company, Celluma devices emit particles of light energy, called photons, which provide compromised cells with the energy to regain and restore vitality naturally, helping to increases the production of the chemical, adenosine triphosphate. This results in an increase in microcirculation, tissue repair, and a decrease in inflammation and pain, Celluma states.
Denise Ryan, vice president of Celluma, explained, “The versatile and multi-functional Celluma can be used as a powerful stand-alone or adjunctive modality following a variety of services, including: surgery, laser, microdermabrasion, microneedling, peels and injections.”